Results from Recent Clinical Trials to be presented at the American Society of Hematology Conference in December 2017
Posted on
New Phase 1/2 Study Data for ALXN1210 as a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at American Society of Hematology (ASH) Meeting
Data from the International PNH Registry Also to Be Presented at the ASH Meeting
Read more here